EligibleTrials

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Recruiting · NCT04239573 · Observational (researchers observe without assigning treatment) · Lead sponsor: ECOG-ACRIN Cancer Research Group

View the official record on ClinicalTrials.gov →
Pancreatic cancer

Interventions studied

Biopsy ProcedureBiospecimen CollectionComputed TomographyEndoscopic UltrasoundEndoscopic Ultrasound-Guided Fine-Needle AspirationMagnetic Resonance ImagingQuality-of-Life AssessmentQuestionnaire AdministrationSurgical Procedure

What this trial is about

The purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers. The study doctors want to compare more frequent monitoring versus less frequent monitoring as well as identify biomarkers which may improve risk detection of transformation to pancreatic cancer. The study doctors want to learn which monitoring method and which biomarkers lead to better outcomes for patients.

Who can take part

Age range
50 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Where it is running

60 locations listed across 41 US states.

Showing 60 of 429 listed sites. See the official record for the complete list.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.